What is the treatment for tertiary syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Tertiary Syphilis

For tertiary syphilis (gummatous or cardiovascular disease, excluding neurosyphilis), treat with benzathine penicillin G 7.2 million units total, administered as three doses of 2.4 million units IM at 1-week intervals. 1, 2

Pre-Treatment Evaluation

Before initiating therapy, you must perform a CSF examination to exclude neurosyphilis in all patients with symptomatic tertiary syphilis 1. This is critical because:

  • Patients with cardiovascular syphilis may require neurosyphilis treatment regimens according to some experts, given the complexity of managing aortitis and its complications 1
  • If CSF shows abnormalities consistent with neurosyphilis, switch to aqueous crystalline penicillin G 18-24 million units per day IV (administered as 3-4 million units every 4 hours or continuous infusion) for 10-14 days 1
  • Cardiovascular manifestations include aortic root dilation, aortic insufficiency, and coronary ostial stenosis—all of which can be life-threatening 3, 4

Standard Treatment Regimen

Benzathine penicillin G 7.2 million units total, given as 2.4 million units IM weekly for 3 consecutive weeks 1, 2, 5

This regimen is identical to late latent syphilis treatment because organisms divide slowly in tertiary disease, requiring prolonged therapy 1

Penicillin Allergy Management

For penicillin-allergic patients:

  • Non-pregnant patients: Doxycycline 100 mg orally twice daily for 28 days OR tetracycline 500 mg orally four times daily for 28 days 1, 5, 6
  • Pregnant patients: Must undergo penicillin desensitization and receive penicillin—there are no acceptable alternatives 1, 5
  • The FDA label confirms doxycycline dosing for syphilis of more than one year's duration at 100 mg orally twice daily for 4 weeks 6

Special Populations

HIV-Infected Patients

  • Perform CSF examination before treatment to rule out neurosyphilis 1
  • Use the same benzathine penicillin regimen (7.2 million units total over 3 weeks) if CSF is normal 1
  • Management complexity requires consultation with an infectious disease specialist 1

Cardiovascular Syphilis Considerations

  • Some experts treat all cardiovascular syphilis cases with neurosyphilis regimens due to the severity and irreversible nature of complications 1
  • Cardiovascular involvement includes aortitis, aortic valve disease, and coronary ostial stenosis—conditions that can cause acute myocardial infarction 3, 4
  • These patients require multidisciplinary management involving infectious disease specialists and cardiovascular surgeons 1, 3

Follow-Up Protocol

Limited data exist for tertiary syphilis follow-up, but clinical response depends on the nature of lesions 1:

  • Monitor quantitative nontreponemal tests at 6,12, and 24 months 1, 5
  • Perform CSF examination if titers increase fourfold, fail to decline appropriately, or new symptoms develop 1, 5
  • Clinical improvement in gummatous lesions should be evident, though cardiovascular damage may be irreversible 7, 8

Critical Pitfalls to Avoid

  • Never skip CSF examination in symptomatic tertiary syphilis—neurosyphilis requires different treatment and missing it leads to progressive neurological damage 1
  • Do not use alternative antibiotics without close monitoring—azithromycin has documented treatment failures due to resistance 1, 7
  • Do not assume serologic tests will be positive—some tertiary syphilis cases have low or negative VDRL titers, making diagnosis challenging 9
  • Always evaluate for both cardiovascular AND neurological involvement—these determine prognosis and may require surgical intervention 9, 3, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Syphilis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Latent Stage Syphilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Syphilis.

Enfermedades infecciosas y microbiologia clinica (English ed.), 2019

Research

Treatment of latent and tertiary syphilis.

Hospital practice (1995), 2000

Research

Two recent cases of tertiary syphilis.

European journal of dermatology : EJD, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.